Health Catalyst (NASDAQ:HCAT – Get Free Report) and Hims & Hers Health (NYSE:HIMS – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.
Profitability
This table compares Health Catalyst and Hims & Hers Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Health Catalyst | -87.69% | -3.52% | -1.77% |
| Hims & Hers Health | -0.56% | 6.10% | 1.52% |
Valuation and Earnings
This table compares Health Catalyst and Hims & Hers Health”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Health Catalyst | $311.14 million | 0.31 | -$177.97 million | ($3.72) | -0.35 |
| Hims & Hers Health | $2.37 billion | 2.28 | $128.37 million | ($0.09) | -263.46 |
Hims & Hers Health has higher revenue and earnings than Health Catalyst. Hims & Hers Health is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Health Catalyst has a beta of 1.63, meaning that its share price is 63% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Health Catalyst and Hims & Hers Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Health Catalyst | 1 | 8 | 4 | 0 | 2.23 |
| Hims & Hers Health | 2 | 11 | 4 | 0 | 2.12 |
Health Catalyst presently has a consensus target price of $2.77, indicating a potential upside of 114.94%. Hims & Hers Health has a consensus target price of $28.90, indicating a potential upside of 21.88%. Given Health Catalyst’s stronger consensus rating and higher possible upside, analysts plainly believe Health Catalyst is more favorable than Hims & Hers Health.
Insider & Institutional Ownership
85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 2.6% of Health Catalyst shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Hims & Hers Health beats Health Catalyst on 9 of the 13 factors compared between the two stocks.
About Health Catalyst
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
About Hims & Hers Health
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.
